Study explores barriers to HIV vaccine response

From Medical Xpress: HIV & AIDS News
September 20, 2013 - 1:05pm

Researchers at The Scripps Research Institute (TSRI) discovered that an antibody that binds and neutralizes HIV likely also targets the body's own "self" proteins. This finding could complicate the development of HIV vaccines designed to elicit this protective antibody, called 4E10, and others like it, as doing so might be dangerous or inefficient.

Share this article »  

Continue reading this article »